Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
Completed · Not applicable
Conditions studied: Breast Carcinoma
In brief
This clinical trial tests how well a mindfulness intervention helps the prevention of chemotherapy-brain (chemo-brain) in women preparing for chemotherapy for breast cancer. Cognitive dysfunction after chemotherapy has been well-documented. Factors that have been used to document and/or have been correlated with chemo brain include self-report and structural brain changes including volume loss. Mindfulness is a type of meditation practice that can be learned to support well-being and decrease stress. Mindfulness is an approach that helps the person increase their awareness of the present moment without judgement. There are data that mindfulness may increase attention and concentration which may prevent some of the side effects from chemotherapy
Key facts
- Study ID
- NCT06219434
- Run by
- Thomas Jefferson University
- People needed
- 15
- Starts
- 2023-11-13
- Expected to finish
- 2025-11-03
- Last updated by the study team
- 2025-12-08
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- 18 years or older
- Breast cancer diagnosis preparing to undergo chemotherapy
You may not qualify if…
- Under the age of 18
- Cannot provide informed consent
Where it is running
- Thomas Jefferson University Hopsital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.